Outcome measures in psoriatic arthritis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current Rheumatology Reports

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11926-996-0039-XPMID 15918995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• OMERACT 7 psoriatic arthritis workshop: synopsis

  2005cited by this paper
• Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

  2005cited by this paper
• Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

  2005cited by this paper
• Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

  2005cited by this paper
• Assessment of outcome in psoriatic arthritis

  2004cited by this paper
• Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

  2004cited by this paper
• Treating psoriatic arthritis: how effective are TNF antagonists?

  2004cited by this paper
• Assessment of patients with psoriatic arthritis: a review of currently available measures.

  2004cited by this paper
• Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.

  2004cited by this paper
• Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis

  2003cited by this paper
• Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study.

  2003cited by this paper
• Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis.

  2003cited by this paper
• Assessment of enthesitis in ankylosing spondylitis

  2003cited by this paper
• Operational definitions and observer reliability of the plain radiographic features of psoriatic arthritis.

  2003cited by this paper
• The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.

  2002cited by this paper
• Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors

  2002cited by this paper
• Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.

  2001cited by this paper
• A method to score radiographic change in psoriatic arthritis

  2001cited by this paper
• ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.

  1999cited by this paper
• Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments.

  1999cited by this paper
• Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality

  1999cited by this paper
• ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials : Part 3: Rheumatoid Arthritis: Response

  1998cited by this paper
• Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

  1998cited by this paper
• Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

  1998cited by this paper
• Radiological assessment in psoriatic arthritis.

  1998cited by this paper
• Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis.

  1997cited by this paper
• Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

  1996cited by this paper
• Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.

  1996cited by this paper
• Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis.

  1996cited by this paper
• American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

  1995cited by this paper
• Reduced joint counts in controlled clinical trials in rheumatoid arthritis.

  1994cited by this paper
• International symposium on psoriatic arthritis.

  1992cited by this paper
• Reliability of measurements of active and damaged joints in psoriatic arthritis.

  1990cited by this paper
• Measurement of patient outcome in arthritis.

  1980cited by this paper

• Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study

  2026cites this paper
• Monitoring psoriatic arthritis in research and clinical practice

  2025cites this paper
• The concept of severity in psoriatic arthritis: a scoping review of the literature.

  2025cites this paper
• Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: a single centre cohort study

  2024cites this paper
• Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study

  2024cites this paper
• Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?

  2023cites this paper
• Which outcomes should always be measured in intervention studies for improving work participation for people with a health problem? An international multistakeholder Delphi study to develop a core outcome set for Work participation (COS for Work)

  2023cites this paper
• Insights into suicidal behavior among psoriatic arthritis patients: A systematic review and a genetic linkage disequilibrium analysis.

  2023cites this paper
• The Psoriatic Arthritis 5-Thermometer Scales (PsA-5Ts): Measurement Properties of a New Multidimensional Composite Tool for the Quick Assessment of the Overall Health Status in Psoriatic Arthritis

  2023cites this paper
• Caesarean section in women with axial spondyloarthritis and psoriatic arthritis: a population-based study

  2023cites this paper
• Fatigue in patients with rheumatic and musculoskeletal diseases: a scoping review on definitions, measurement instruments, determinants, consequences and interventions

  2023cites this paper
• Effectiveness of functional training versus resistance exercise in patients with psoriatic arthritis: randomized controlled trial

  2023influential citation
• Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database

  2023cites this paper
• Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA

  2023cites this paper
• Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors

  2022cites this paper
• Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard care

  2022influential citation
• Serum salusin-α and salusin-β levels in patients with psoriatic arthritis

  2022cites this paper
• Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE

  2022cites this paper
• Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab

  2022cites this paper
• Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance

  2022influential citation
• Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice?

  2022cites this paper
• The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome

  2021cites this paper
• Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk

  2021cites this paper
• Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers

  2021cites this paper
• Psychologic Morbidity Among Psoriatic Arthritis Patients in Remission or With Low Disease Activity

  2020cites this paper
• Conducting research in psoriatic arthritis: the emerging role of patient research partners

  2020cites this paper
• Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study

  2020cites this paper
• Treatment Goals in Psoriasis: Which Outcomes Matter Most?

  2020cites this paper
• Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis

  2020cites this paper
• Predicting functional disability in patients with spondyloarthritis using a CRP-based algorithm: A 3-year prospective study.

  2020cites this paper
• Psoriatic Arthritis Disease Activity During and After Pregnancy: A Prospective Multicenter Study

  2019cites this paper
• Vaspin, neutrophil gelatinase-associated lipocalin and apolipoprotein levels in patients with psoriatic arthritis.

  2019cites this paper
• Routine Assessment of Patient Index Data 3 Score and Psoriasis Quality of Life Assess Complementary Yet Different Aspects of Patient-Reported Outcomes in Psoriasis and Psoriatic Arthritis

  2018cites this paper
• Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA

  2018cites this paper
• Early response to therapy predicts 6-month and 1-year disease activity outcomes in psoriatic arthritis patients

  2018cites this paper
• Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review.

  2018cites this paper
• Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?

  2018cites this paper
• Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study

  2018cites this paper
• A resistance exercise program improves functional capacity of patients with psoriatic arthritis: a randomized controlled trial

  2018cites this paper
• PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE.

  2018cites this paper
• The psychosocial burden of psoriatic arthritis.

  2017cites this paper
• Eficacia de los fármacos antirreumáticos modificadores de la enfermedad sintéticos en artritis psoriásica: una revisión sistemática

  2017cites this paper
• Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

  2017cites this paper
• Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus

  2017cites this paper
• Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti‐rheumatic agents for the treatment of psoriatic arthritis

  2017cites this paper
• Psoriatic Arthritis.

  2017cites this paper
• Gender specific differences in patients with psoriatic arthritis

  2017cites this paper
• The association of clinical parameters and ultrasound verified inflammation with patients' and physicians' global assessments in psoriatic arthritis.

  2016cites this paper
• A Concrete and Viable Example of Multimaterial Body The Evolution Project Main Outcomes

  2016cites this paper
• The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial

  2016cites this paper
• Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis

  2016cites this paper
• Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy

  2016influential citation
• Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1)

  2016cites this paper
• Outcome Measures of Psoriasis in Clinical Trials: An Overview

  2016cites this paper
• Marine n-3 Polyunsaturated Fatty Acids in Psoriatic Arthritis – Inflammation and Cardiac Autonomic and Hemodynamic Function

  2016cites this paper
• A Concrete and Viable Example of Multimaterial Body

  2016cites this paper
• Validation of disease activity indices using the 28 joint counts in systemic sclerosis.

  2016cites this paper
• Patients with Psoriatic Arthritis Fulfilling the Minimal Disease Activity Criteria Do Not Have Swollen and Tender Joints, but Have Active Skin

  2016cites this paper
• Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis.

  2016cites this paper
• Früherkennung der Komorbidität bei Psoriasis: Konsensusempfehlungen der Nationalen Konferenz zur Versorgung der Psoriasis

  2015cites this paper
• Enhanced Patient Involvement and the Need to Revise the Core Set — Report from the Psoriatic Arthritis Working Group at OMERACT 2014

  2015cites this paper
• Measuring psoriatic disease in clinical practice. An expert opinion position paper.

  2015cites this paper
• Patient’s Global Assessment as an Outcome Measure for Psoriatic Arthritis in Clinical Practice: A Surrogate for Measuring Low Disease Activity?

  2015cites this paper
• Helliwell and Coates byusing the DAPSA score : response to letter Defining remission and treatment success

  2015cites this paper
• Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis

  2015cites this paper
• Defining remission and treatment success using the DAPSA score: response to letter by Helliwell and Coates

  2015cites this paper
• The Difficult Task of Assessing Psoriatic Arthritis

  2015cites this paper
• Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

  2015cites this paper
• Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.

  2015cites this paper
• Is There Subclinical Synovitis in Early Psoriatic Arthritis? A Clinical Comparison With Gray-Scale and Power Doppler Ultrasound

  2014cites this paper
• Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

  2014cites this paper
• Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.

  2014cites this paper
• Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors

  2014cites this paper
• Aiming for remission in psoriatic arthritis

  2014cites this paper
• How Much Is Fatigue Explained by Standard Clinical Characteristics of Disease Activity in Patients With Inflammatory Arthritis? A Longitudinal Study

  2014cites this paper
• A review of disease activity measures for psoriatic arthritis: what is the best approach?

  2014influential citation
• Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial.

  2014cites this paper
• Psoriatic arthritis indices.

  2014cites this paper
• Psoriatic Arthritis: Clinical Review and Update

  2014cites this paper
• Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials

  2014cites this paper
• Development of a Disease Activity and Responder Index for Psoriatic Arthritis — Report of the Psoriatic Arthritis Module at OMERACT 11

  2014cites this paper
• The Role of Notch Signalling in the Pathogenesis of Psoriasis

  2013cites this paper
• Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry.

  2013cites this paper
• 33 – Assessment of Health Outcomes

  2013cites this paper
• Outcome Measures in Psoriasis and Psoriatic Arthritis

  2013cites this paper
• Application and Modifications of Minimal Disease Activity Measures for Patients with Psoriatic Arthritis Treated with Adalimumab: Subanalyses of ADEPT

  2013influential citation
• Outcome assessment in psoriatic arthritis

  2013cites this paper
• Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement.

  2013cites this paper
• Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

  2013cites this paper
• IL-17 in the Rheumatologist's Line of Sight

  2013cites this paper
• Clinical manifestations and diagnosis of RA and psoriatic arthritis: distinct and complex disease entities Part 2

  2013cites this paper
• Chapitre 4 – Spondyloarthrites

  2013cites this paper
• Construct Validity of the Modified Numeric Rating Scale of Patient Global Assessment in Psoriatic Arthritis

  2012cites this paper
• Measuring Disease Activity in Psoriatic Arthritis

  2012cites this paper
• 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis.

  2012cites this paper
• Team rehabilitation and health care utilization in chronic inflammatory arthritis patients

  2012cites this paper
• Swollen joint count in psoriatic arthritis is associated with progressive radiological damage in hands and feet.

  2012cites this paper
• The Radiological Assessment of Axial Involvement in Psoriatic Arthritis

  2012cites this paper
• Power of crowdsourcing: novel methods of data collection in psoriasis and psoriatic arthritis.

  2012cites this paper
• Dr. Cauli, et al reply

  2012cites this paper